MDL No. 3180 is a federal multidistrict litigation, not a class action, consolidating individual Dupixent and T-cell lymphoma lawsuits before Judge Zahid N. Quraishi in the District of New Jersey for coordinated pretrial proceedings. Each plaintiff keeps their own individual claim and their own outcome. The MDL only combines the evidence-gathering and pretrial process across many similar cases filed in federal court.
The nuance most explanations skip is that timing matters more than people realize, both because statute of limitations rules vary sharply by state and by when you knew or should have known about a possible link, and because bellwether trial outcomes can shape settlement leverage for everyone even though your own case is still decided on its own facts. It’s also worth knowing that “class action” language floating around online is often just imprecise, not a sign anyone is being pulled into someone else’s case.
If you’re trying to figure out where your own timeline stands, Robert Baker personally reviews every Dupixent case his firm accepts, as an active trial attorney rather than a referral aggregator who hands cases off. A free, confidential case review can tell you where you stand before a filing deadline passes. Here’s what MDL No. 3180 actually is, how bellwether trials work, and what joining involves.
What Is MDL No. 3180, and Is It the Same as a Class Action?
MDL No. 3180 is not a class action. It is a coordinated federal proceeding where individual Dupixent and T-cell lymphoma lawsuits are transferred into one court for shared pretrial handling, while each case remains legally separate.
This distinction matters because the two structures work very differently for the people involved.
In a class action, one or a small number of named plaintiffs represent an entire group. Everyone in the class typically receives a similar payout, regardless of how severe their individual injury was. Filing an individual claim within an MDL works differently:
- You file your own lawsuit, naming your own facts, your own diagnosis, and your own treatment history
- Your case shares the discovery and evidence-gathering process with other similar cases
- Your outcome is tied to your own medical records and losses, not averaged with anyone else’s
- You retain your own attorney-client relationship and decision-making authority over your case
MDL No. 3180, formed after the June 2026 creation of MDL No. 3180, currently consolidates federal Dupixent lawsuits alleging that the drug’s use was linked to cutaneous T-cell lymphoma diagnoses, with claims centered on inadequate warning about that risk. The case was formally transferred to the District of New Jersey by the U.S. Judicial Panel on Multidistrict Litigation. These are allegations made by plaintiffs. The manufacturer disputes them, and causation between Dupixent and any individual patient’s diagnosis has not been decided by a court.
How Do Bellwether Trials Work, and Why Do They Matter to My Individual Case?
Bellwether trials are a small number of representative cases selected from within an MDL to go to trial first, and their outcomes often shape how later settlement discussions proceed for everyone still in the litigation. Your case does not need to be selected as a bellwether for those results to matter to you.
Once an MDL reaches a sufficient size, the court and the parties typically select a handful of cases that reflect common fact patterns in the litigation. These cases proceed through trial while the broader group of cases continues through the coordinated pretrial process behind them.
The verdicts or settlements from those early trials tend to become reference points. If a bellwether trial results in a substantial verdict, it can strengthen settlement positions across the litigation. If a bellwether trial goes poorly for plaintiffs, it can affect how manufacturers approach the remaining cases as well.
None of this changes the fact that your own case still rises or falls on your own medical records, your own diagnosis timeline, and your own documented history. Bellwether results influence the environment your case sits in, not the underlying facts of your claim.
How Much Time Do I Have to File a Dupixent Lawsuit?
There is no single deadline that applies to every Dupixent case, since statutes of limitations vary by state and often depend on when you knew or reasonably should have known about a possible link between the drug and your diagnosis. Waiting to find out your specific deadline carries real risk.
Some states begin the clock on the date of your CTCL diagnosis. Others apply a discovery rule, which starts the clock on the date you reasonably discovered, or should have discovered, that Dupixent may have played a role in your condition. That discovery date is not always obvious, especially since eczema and early CTCL symptoms can look similar, a diagnostic overlap that has led some patients to a misdiagnosis before the real picture became clear.
A few things worth understanding about your own timeline:
- Your state of residence and the state where you were treated can both affect which limitations period applies
- The discovery rule generally protects patients whose diagnosis was delayed or initially misread, but only if the delay is documented
- Missing a filing deadline can permanently bar a claim, regardless of how strong the underlying facts are
- Ongoing MDL proceedings do not pause or extend an individual state’s filing deadline
Because these rules are fact-specific and vary meaningfully by state, the most reliable way to know where you stand is a case review rather than guessing based on general information.
What Does Joining the MDL Actually Involve?
Joining MDL No. 3180 generally means filing your own individual lawsuit in federal court, which then gets transferred into the coordinated proceeding for pretrial handling. It does not mean signing onto an existing case or giving up control over your own claim.
The process typically follows a consistent sequence once a case is ready to file.
- Case evaluation. An attorney reviews your Dupixent prescription history, treatment records, and CTCL diagnosis to assess whether your facts fit the litigation’s allegations.
- Records gathering. Medical records, prescription history, and diagnostic records are collected to document your specific timeline.
- Filing. Your individual lawsuit is filed in the appropriate federal court.
- Transfer. If your case involves similar claims already part of the litigation, it is typically transferred into MDL No. 3180 for coordinated pretrial proceedings.
- Ongoing pretrial process. Your case proceeds through shared discovery and case-management deadlines alongside other cases, while remaining legally your own.
- Resolution. Depending on how the litigation develops, individual cases may resolve through settlement or trial.
Filing now, rather than waiting to see how the litigation develops, generally preserves your position in the process and gives your attorney more time to build your file properly.
What Does Baker Legal Team Do Differently in MDL Cases?
Baker Legal Team handles Dupixent MDL cases through direct, personal attorney involvement rather than a referral-based intake model. Robert B. Baker, a Board Certified Civil Trial Lawyer with The Florida Bar, personally reviews every case his firm accepts.
This background matters in coordinated litigation like MDL No. 3180. Robert previously served as Rhode Island’s State Liaison Counsel in the multidistrict breast implant litigation, coordinating claims against a manufacturer across multiple states, a structure similar to how mass tort MDLs run today.
He is also an active trial attorney, not a firm that settles every case as a matter of course. That distinction matters in mass tort litigation specifically, since a willingness to actually try a case, including participating meaningfully in bellwether proceedings, can affect how seriously a claim is taken throughout the process.
Bottom Line
MDL No. 3180 is a coordinated federal process, not a class action, and each plaintiff’s case is decided on its own facts even while sharing pretrial proceedings with others. Bellwether trial outcomes can shape the broader settlement environment, but they don’t determine your individual case. The biggest risk right now isn’t the litigation process itself, it’s running out of time under your state’s statute of limitations before you’ve even had your situation reviewed.
If you were prescribed Dupixent and later diagnosed with T-cell lymphoma, a free, confidential consultation can help clarify where your timeline stands.
Frequently Asked Questions
Is the Dupixent MDL the same as a Dupixent class action lawsuit?
No, the Dupixent MDL is not the same as a class action lawsuit. MDL No. 3180 consolidates individual lawsuits for shared pretrial proceedings, while each plaintiff’s case remains separate and is decided on its own facts.
How do I join the Dupixent MDL?
You join the Dupixent MDL by filing your own individual lawsuit in federal court, which is then typically transferred into the coordinated proceeding if it involves similar claims already part of the litigation.
Does my case have to be a bellwether trial to matter?
No, your case does not have to be selected as a bellwether trial to matter. Bellwether outcomes can influence the broader litigation environment, but your individual claim is still decided based on your own medical records and history.
How much time do I have to file a Dupixent lawsuit?
The time you have to file a Dupixent lawsuit depends on your state’s statute of limitations and, in many states, when you knew or reasonably should have known about a possible link between Dupixent and your diagnosis, which is why a case-specific review matters.
What happens if I was initially misdiagnosed before learning about the Dupixent and CTCL connection?
If you were initially misdiagnosed, many states’ discovery rules account for that delay by starting the filing clock from when you reasonably discovered the connection rather than from your original diagnosis date, though this depends on documentation and your specific state’s rules.
Do I need to already have a lawyer to explore filing a Dupixent claim?
No, you do not need to already have a lawyer to explore filing a Dupixent claim, since a free consultation is generally the starting point for reviewing your prescription history, diagnosis, and timeline.
Does filing a Dupixent MDL claim cost anything upfront?
No, filing a Dupixent MDL claim with a firm working on contingency does not cost anything upfront, since fees typically apply only if a recovery is obtained.